Amgen Played Waiting Game Before Agreeing $3.7bn ChemoCentryx Deal

SEC Filings Show Tactical Negotiations

 
• By Andrew McConaghie
  
Amgen
Amgen first opened talks with ChemoCentryx in early 2020, eventually paying $3.7bn for the company. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business